Nanotechnology Now

Our NanoNews Digest Sponsors


Heifer International

Wikipedia Affiliate Button


DHgate

Home > Press > P2i raises £4.1m/$6.7m to exploit opportunities in nano-coating technology worldwide

Abstract:
P2i Ltd, the world leader in liquid-repellent nano-coating technology, has raised £4.1 million ($6.7 million), from new and existing shareholders, to support its accelerating commercialisation and international growth.

P2i raises £4.1m/$6.7m to exploit opportunities in nano-coating technology worldwide

London, UK | Posted on July 20th, 2009

P2i was established in 2004 to commercialise liquid-repellent treatments developed by the Ministry of Defence. Its revolutionary technology helps customers protect and improve a wide and growing range of products including performance textiles (such as hiking and military boots; running and golf shoes), hearing aids, laboratory consumables such as pipette tips, and a wide range of filtration products.

This Series C funding round comes as the company accelerates its growth across a wide range of markets. New investor Swarraton Partners led the round and, along with Naxos Capital Partners, provided most of the funds. Existing shareholder Unilever Ventures also participated in the round.

Carl Francis, P2i's Chief Executive, commented:

"This substantial new investment, particularly in light of today's tough fundraising environment, is a clear endorsement of our leading position in liquid-repellent nano-coating technology.

"It will enable us to exploit the international and multi-market potential for P2i and underpins our ability to work on an equal footing with some of the world's leading industrial, scientific and consumer brand players."

On his new shareholders, Mr Francis added "We are delighted to bring high quality investors such as Swarraton and Naxos on board. All of our shareholders, which include Porton Capital, Unilever Ventures, and Ploughshare Innovations, have great track records in helping companies like ours realise their full potential."

Stephen Brooke, Swarraton's Managing Partner, said:

"At Swarraton, we back companies with world class technology, solid management, and the potential to make a big impact in large markets. P2i is a perfect fit for us."



The new money will be invested in four main areas:

* operational infrastructure and facilities;
* marketing and sales capacity, including further development of the company's US organisation;
* capital equipment; and
* R&D.



Part of the manufacturing expenditure will be devoted to the development of patented continuous plasma-processing systems supporting higher-volume applications of P2i's technology, opening up fresh business opportunities, particularly in textiles, apparel, and FMCG products.

P2i's liquid-repellent nano-coating process has already been successfully applied to a wide range of products and markets, but holds the potential for further commercialisation in many more - for example in engineered textiles, protective gloves, hospital gowns and wound care, plus industrial lenses and solar cells.

In consumer sectors the presence of P2i's technology is indicated by its consumer brand, ion-mask™, now available in premium products from Ecco, Hi-TEC, Van Dal and leading uniform/workwear boot brand MAGNUM. P2i is also in discussions with a number of other world leading footwear brands, as well as several premium-brand sunglass manufacturers.

####

About P2i Ltd
How P2i’s technology works

P2i’s technology works by applying a nanometre-thick polymer layer over the entire surface of a product. Using an ionised gas (plasma) this layer is molecularly bound to the surface and will not leach away. The process confers superior oil and water repellency by reducing the surface energy to ultra-low levels – down to one third that of PTFE (polytetrafluoroethylene). In footwear and textile applications, P2i’s technology also minimises liquid absorption from outside elements and evaporated perspiration.

For more information, please click here

Contacts:
College Hill:
Andrew Vincent
+44(0)1869 353812

Zoe March
+44(0)1869 353805

Copyright © P2i Ltd

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Hybrid nanoantennas -- next-generation platform for ultradense data recording April 28th, 2016

Superfast light source made from artificial atom April 28th, 2016

Arrowhead Pharmaceuticals Files for Regulatory Clearance to Begin Phase 1/2 Study of ARC-521 April 28th, 2016

The Translational Research Center at the University Hospital of Erlangen in Germany uses the ZetaView from Particle Metrix to quantify extracellular vesicles such as exosomes April 28th, 2016

VC/Funding/Angel financing/Loans/Leases/Crowdfunding

ORIG3N Added to Companies Presenting at Harris & Harris Group's Annual Meeting, Tuesday June 7, 2016, the New York Genome Center April 27th, 2016

Philadelphia Mathematician Robert Clark Turns to Crowdfunding to Support Nanotechnology Research That Could Lead to ‘Flying’ Cars and Space Elevator April 4th, 2016

Harris & Harris Group Announces Formation of Co-Investment Fund for Accredited Investors March 9th, 2016

Clinatec Announces €30M Fundraising Campaign to Speed Research In Treatment of Neurodegenerative Diseases, Cancer and Motor Disabilities February 24th, 2016

Materials/Metamaterials

Hybrid nanoantennas -- next-generation platform for ultradense data recording April 28th, 2016

University of Illinois researchers create 1-step graphene patterning method April 27th, 2016

NREL finds nanotube semiconductors well-suited for PV systems April 27th, 2016

Atomic magnets using hydrogen and graphene April 27th, 2016

Announcements

Hybrid nanoantennas -- next-generation platform for ultradense data recording April 28th, 2016

Superfast light source made from artificial atom April 28th, 2016

Arrowhead Pharmaceuticals Files for Regulatory Clearance to Begin Phase 1/2 Study of ARC-521 April 28th, 2016

The Translational Research Center at the University Hospital of Erlangen in Germany uses the ZetaView from Particle Metrix to quantify extracellular vesicles such as exosomes April 28th, 2016

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







Car Brands
Buy website traffic